Displaying 2401 - 2420 of 4794
1603004 Informal Interpretation
1603005 Informal Interpretation
1603003 Informal Interpretation
FTC Commissioner Julie Brill to Resign
1603002 Informal Interpretation
Statement of FTC Chairwoman Edith Ramirez on the U.S. Supreme Court's Decision in McWane Inc. v. FTC
FTC Approves Final Order Preserving Competition Among Outpatient Dialysis Clinics in Laredo, Texas
Rangers Renal Holding, LP; US Renal Care, Inc.; Dialysis Parent, LLC and Dialysis HoldCo, LLC, In the Matter of
To settle charges that its acquisition of DSI Renal would substantially lessen competition for outpatient dialysis services in Laredo, Texas, U.S. Renal agreed to divest three clinics to Satellite Healthcare, Inc.
INNOVATE2016: The role of the FTC and federal regulators in Silicon Valley (Video)
FTC Amicus Brief Urges Appeals Court to Correct Legal Errors in District Court’s Antitrust Analysis of Reverse-Payment Agreement
In re Wellbutrin Antitrust Litigation
FTC Staff: Proposed Health Care Legislation in West Virginia Would Likely Be Anticompetitive and Harm Consumers
Prepared Statement of the Federal Trade Commission On "Oversight of the Enforcement of the Antitrust Laws"
FTC Chairwoman Ramirez Testifies Before Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights
1603001 Informal Interpretation
Quarterly Litigation Status Report- March 2016
FTC Puts Conditions on Drug Manufacturer Hikma Pharmaceuticals PLC’s Proposed Acquisition of Roxane Laboratories Inc. and Boehringer Ingelheim Roxane, Inc. from Boehringer Ingelheim Corporation
FTC Approves Modified Consent Order for Mylan N.V.
Displaying 2401 - 2420 of 4794